⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hypopharynx cancer

Every month we try and update this database with for hypopharynx cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum CancerNCT01066741
Oropharynx Canc...
Hypopharynx Can...
Homeodent®
1.4% Sodium Bic...
18 Years - 85 YearsCentre Leon Berard
Pembrolizumab in Combination With CRT for LA-SCCHNNCT02586207
Head and Neck C...
Squamous Cell C...
Oral Cavity Can...
Oropharynx Canc...
Hypopharynx Can...
Larynx Cancer
Laryngeal Cance...
pembrolizumab (...
Cisplatin
Radiation
18 Years - Sanford Health
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCCNCT00158678
Oral Cancer
Oropharynx Canc...
Hypopharynx Can...
IMRT 75 Gy
Conventional ra...
concomitant cis...
18 Years - Groupe Oncologie Radiotherapie Tete et Cou
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx PreservationNCT00169247
Larynx Cancer
Hypopharynx Can...
cetuximab
Cisplatin
Radiotherapy 70...
18 Years - 75 YearsGroupe Oncologie Radiotherapie Tete et Cou
Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx CarcinomaNCT00169182
Larynx Cancer
Hypopharynx Can...
DOCETAXEL
Cisplatin
5-Fluoro-3-Pyri...
18 Years - 75 YearsGroupe Oncologie Radiotherapie Tete et Cou
Special Care Patterns for Elderly HNSCC Patients Undergoing RadiotherapyNCT05337631
HNSCC
Oral Cavity Can...
Oropharynx Canc...
Hypopharynx Can...
Larynx Cancer
65 Years - University Hospital Freiburg
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr SurvivorsNCT05798780
Oral Cavity Can...
Oropharynx Canc...
Hypopharynx Can...
Larynx Cancer
ENHANCE Interve...
ENHANCE Interve...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx CancerNCT01516996
Oropharyngeal C...
Hypopharyngeal ...
docetaxel and c...
IMRT
Nimotuzumab
18 Years - 70 YearsThe Second People's Hospital of Sichuan
Adaptive Radiotherapy for Head and Neck CancerNCT03096808
Head and Neck C...
Paranasal Sinus...
Oropharynx Canc...
Oral Cavity Can...
Nasopharynx Can...
Larynx Cancer
Hypopharynx Can...
Adaptive Radiot...
18 Years - Memorial Sloan Kettering Cancer Center
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx CancerNCT01516996
Oropharyngeal C...
Hypopharyngeal ...
docetaxel and c...
IMRT
Nimotuzumab
18 Years - 70 YearsThe Second People's Hospital of Sichuan
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCCNCT00162708
Oropharynx Canc...
Oral Cancer
Hypopharynx Can...
Larynx Cancer
Radiotherapy 62...
Radiotherapy 62...
CDDP, 5 Fu
40 Years - 75 YearsGustave Roussy, Cancer Campus, Grand Paris
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck CancerNCT00080028
Head and Neck C...
Oropharynx Canc...
Larynx Cancer
Hypopharynx Can...
Motexafin Gadol...
18 Years - Pharmacyclics LLC.
A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy PatientsNCT03039465
Laryngeal Cance...
Hypopharynx Can...
Modified Trans-...
- HealthCare Global Enterprise Ltd.
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersNCT04892875
Head and Neck C...
Squamous Cell C...
Oral Cavity Squ...
Oral Cavity Can...
Oropharynx Canc...
Oropharynx Squa...
Larynx Cancer
Pharynx Cancer
Hypopharynx Can...
Hypopharynx Squ...
Zimberelimab
Etrumadenant
Cisplatin
Radiation
18 Years - Vanderbilt-Ingram Cancer Center
Cell-free Tumor DNA in Head and Neck Cancer PatientsNCT03942380
Head and Neck C...
Head and Neck N...
Head and Neck S...
Oropharynx Canc...
Oropharynx Neop...
Oropharynx Carc...
Oral Cavity Can...
Oral Cancer
Oral Neoplasm
Larynx Cancer
Larynx Carcinom...
Larynx Neoplasm
Nasopharyngeal ...
Nasopharyngeal ...
Nasopharynx Neo...
Hypopharynx Can...
Hypopharynx Neo...
Hypopharynx Car...
Sinonasal Carci...
Thyroid Carcino...
Thyroid Cancer
Thyroid Neoplas...
Salivary Gland ...
Salivary Gland ...
Salivary Gland ...
Sinonasal Cance...
Sinonasal Neopl...
Liquid biopsy
18 Years - Rigshospitalet, Denmark
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaNCT03082534
HNSCC
Lip SCC
Oral Cavity Can...
Oropharynx Canc...
Larynx Cancer
Hypopharynx Can...
Nasopharynx Can...
Sinonasal Carci...
Cutaneous Squam...
Head and Neck N...
Head and Neck C...
Head and Neck S...
Pembrolizumab, ...
18 Years - University of California, San Diego
Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal CarcinomaNCT04995120
Laryngeal Cance...
Hypopharynx Can...
Laryngeal Neopl...
chemotherapy TP...
18 Years - 75 YearsFudan University
Immunological Function After Radiation With Either Proton or Photon TherapyNCT06016699
HNSCC
Head and Neck C...
Oropharynx Canc...
Hypopharynx Can...
Larynx Cancer
blood draws
18 Years - University Medical Center Groningen
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersNCT04892875
Head and Neck C...
Squamous Cell C...
Oral Cavity Squ...
Oral Cavity Can...
Oropharynx Canc...
Oropharynx Squa...
Larynx Cancer
Pharynx Cancer
Hypopharynx Can...
Hypopharynx Squ...
Zimberelimab
Etrumadenant
Cisplatin
Radiation
18 Years - Vanderbilt-Ingram Cancer Center
A Pilot Study of Acupuncture Treatment for DysphagiaNCT00797732
Carcinomas, Squ...
Dysphagia
Acupuncture
18 Years - Dana-Farber Cancer Institute
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCCNCT00158652
Oral Cancer
Oropharynx Canc...
Hypopharynx Can...
Larynx Cancer
Conventional ra...
middle accelera...
very accelerate...
5FU, Paraplatin
20 Years - 75 YearsGroupe Oncologie Radiotherapie Tete et Cou
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr SurvivorsNCT05798780
Oral Cavity Can...
Oropharynx Canc...
Hypopharynx Can...
Larynx Cancer
ENHANCE Interve...
ENHANCE Interve...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum CancerNCT01066741
Oropharynx Canc...
Hypopharynx Can...
Homeodent®
1.4% Sodium Bic...
18 Years - 85 YearsCentre Leon Berard
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersNCT04892875
Head and Neck C...
Squamous Cell C...
Oral Cavity Squ...
Oral Cavity Can...
Oropharynx Canc...
Oropharynx Squa...
Larynx Cancer
Pharynx Cancer
Hypopharynx Can...
Hypopharynx Squ...
Zimberelimab
Etrumadenant
Cisplatin
Radiation
18 Years - Vanderbilt-Ingram Cancer Center
Cell-free Tumor DNA in Head and Neck Cancer PatientsNCT03942380
Head and Neck C...
Head and Neck N...
Head and Neck S...
Oropharynx Canc...
Oropharynx Neop...
Oropharynx Carc...
Oral Cavity Can...
Oral Cancer
Oral Neoplasm
Larynx Cancer
Larynx Carcinom...
Larynx Neoplasm
Nasopharyngeal ...
Nasopharyngeal ...
Nasopharynx Neo...
Hypopharynx Can...
Hypopharynx Neo...
Hypopharynx Car...
Sinonasal Carci...
Thyroid Carcino...
Thyroid Cancer
Thyroid Neoplas...
Salivary Gland ...
Salivary Gland ...
Salivary Gland ...
Sinonasal Cance...
Sinonasal Neopl...
Liquid biopsy
18 Years - Rigshospitalet, Denmark
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: